Olema Pharmaceuticals Inc
Olema Pharmaceuticals Inc (OLMA) Implied Volatility Current
OLMA implied volatility is 113%. IV Rank is 38%, placing current premiums in the middle of their 52-week range.
Read more
Tracking OLMA implied volatility helps you identify when options premiums on Olema Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Olema Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when OLMA IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Olema Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For OLMA, tracking metrics like OLMA IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on OLMA signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc.
was incorporated in 2006 and is headquartered in San Francisco, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where OLMA implied volatility sits today versus where it has been. Our scanner ranks Olema Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in OLMA IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Olema Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is below its typical range - premiums look reasonable for buyers.
As of September 22, 2026
Trade options with IV on your side
Track OLMA IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→